T cells from triple negative breast cancer patients were enriched in vitro and activated to express PD1, lymphocyte-activation gene 3 (LAG3), mucin-domain containing-3 (TIM3) immune checkpoint receptors then cell membranes were isolated and mixed with NPs. This evidence concerns the gene LAG3 and triple-negative breast carcinoma.